Wellness Plans & Weight-management
with Semaglutide and Tirzepatide
Semaglutide (Ozempic) is a GLP-1 receptor meaning, it mimics the body’s natural gut-derived incretin peptide hormones that secrete in response to a meal. This allows for increased insulin secretion, decreased glucose (sugar) production in the liver, and delays gastric emptying – which makes you feel fuller longer and satisfied by smaller meal portions. It has been approved to regulate Diabetes and High Blood Sugar/Cholesterol, but the additional, long-term benefits of the medication work from the inside out to improve overall metabolic health and provides cardio-protective benefits that aid in weightloss and management. Suitable for those struggling with abnormal weight gain due to hormone imbalance, metabolic dysfunction, genetics, birth control, other medications/conditions, and much more.
Tirzepatide (Monjauro) is a GLP-2 receptor. It produces similar, but less pronounced effects on gastric motility and acid production as GLP-1, but has little or no effect on insulin secretion. Dosages are much higher than Semaglutide but results are similar. 1-3lbs lost per week is considered healthy when taking both medications. Moreover, these medications suppress the body’s weight regain mechanisms.